Tag:
CPP-109
Latest Headlines
Latest Headlines
Catalyst's cocaine addiction med fails mid-stage trial
Catalyst Pharmaceutical Partners says its lead drug candidate CPP-109, a treatment for cocaine addiction, failed to meet its primary endpoint in a mid-stage trial. Results from the trial did not show
Catalyst modifies R&D plans, looks for partners
Catalyst Pharmaceutical Partners crunched the numbers and opted to halt new enrollment in a mid-stage trial to ensure it has the funds on hand to continue its work "well into 2010." The Phase II
